Cargando…
SGLT inhibitors as antidiabetic agents: a comprehensive review
Diabetes is one of the most common disorders that substantially contributes to an increase in global health burden. As a metabolic disorder, diabetes is associated with various medical conditions and diseases such as obesity, hypertension, cardiovascular diseases, and atherosclerosis. In this review...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048284/ https://www.ncbi.nlm.nih.gov/pubmed/35494673 http://dx.doi.org/10.1039/c9ra08706k |
_version_ | 1784695899039989760 |
---|---|
author | Kshirsagar, Rahul P. Kulkarni, Abhishek A. Chouthe, Rashmi S. Pathan, Shahebaaz K. Une, Hemant D. Reddy, G. Bhanuprakash Diwan, Prakash V. Ansari, Siddique Akber Sangshetti, Jaiprakash N. |
author_facet | Kshirsagar, Rahul P. Kulkarni, Abhishek A. Chouthe, Rashmi S. Pathan, Shahebaaz K. Une, Hemant D. Reddy, G. Bhanuprakash Diwan, Prakash V. Ansari, Siddique Akber Sangshetti, Jaiprakash N. |
author_sort | Kshirsagar, Rahul P. |
collection | PubMed |
description | Diabetes is one of the most common disorders that substantially contributes to an increase in global health burden. As a metabolic disorder, diabetes is associated with various medical conditions and diseases such as obesity, hypertension, cardiovascular diseases, and atherosclerosis. In this review, we cover the scientific studies on sodium/glucose cotransporter (SGLT) inhibitors published during the last decade. Our focus on providing an exhaustive overview of SGLT inhibitors enabled us to present their chemical classification for the first time. |
format | Online Article Text |
id | pubmed-9048284 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Royal Society of Chemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-90482842022-04-28 SGLT inhibitors as antidiabetic agents: a comprehensive review Kshirsagar, Rahul P. Kulkarni, Abhishek A. Chouthe, Rashmi S. Pathan, Shahebaaz K. Une, Hemant D. Reddy, G. Bhanuprakash Diwan, Prakash V. Ansari, Siddique Akber Sangshetti, Jaiprakash N. RSC Adv Chemistry Diabetes is one of the most common disorders that substantially contributes to an increase in global health burden. As a metabolic disorder, diabetes is associated with various medical conditions and diseases such as obesity, hypertension, cardiovascular diseases, and atherosclerosis. In this review, we cover the scientific studies on sodium/glucose cotransporter (SGLT) inhibitors published during the last decade. Our focus on providing an exhaustive overview of SGLT inhibitors enabled us to present their chemical classification for the first time. The Royal Society of Chemistry 2020-01-09 /pmc/articles/PMC9048284/ /pubmed/35494673 http://dx.doi.org/10.1039/c9ra08706k Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Chemistry Kshirsagar, Rahul P. Kulkarni, Abhishek A. Chouthe, Rashmi S. Pathan, Shahebaaz K. Une, Hemant D. Reddy, G. Bhanuprakash Diwan, Prakash V. Ansari, Siddique Akber Sangshetti, Jaiprakash N. SGLT inhibitors as antidiabetic agents: a comprehensive review |
title | SGLT inhibitors as antidiabetic agents: a comprehensive review |
title_full | SGLT inhibitors as antidiabetic agents: a comprehensive review |
title_fullStr | SGLT inhibitors as antidiabetic agents: a comprehensive review |
title_full_unstemmed | SGLT inhibitors as antidiabetic agents: a comprehensive review |
title_short | SGLT inhibitors as antidiabetic agents: a comprehensive review |
title_sort | sglt inhibitors as antidiabetic agents: a comprehensive review |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048284/ https://www.ncbi.nlm.nih.gov/pubmed/35494673 http://dx.doi.org/10.1039/c9ra08706k |
work_keys_str_mv | AT kshirsagarrahulp sgltinhibitorsasantidiabeticagentsacomprehensivereview AT kulkarniabhisheka sgltinhibitorsasantidiabeticagentsacomprehensivereview AT choutherashmis sgltinhibitorsasantidiabeticagentsacomprehensivereview AT pathanshahebaazk sgltinhibitorsasantidiabeticagentsacomprehensivereview AT unehemantd sgltinhibitorsasantidiabeticagentsacomprehensivereview AT reddygbhanuprakash sgltinhibitorsasantidiabeticagentsacomprehensivereview AT diwanprakashv sgltinhibitorsasantidiabeticagentsacomprehensivereview AT ansarisiddiqueakber sgltinhibitorsasantidiabeticagentsacomprehensivereview AT sangshettijaiprakashn sgltinhibitorsasantidiabeticagentsacomprehensivereview |